Laron Z - Search Results

1

Carbohydrate metabolism in primary growth hormone resistance (Laron syndrome) before and during insulin-like growth factor-I treatment.

Laron Z, Avitzur Y, Klinger B. Laron Z, et al. Metabolism. 1995 Oct;44(10 Suppl 4):113-8. doi: 10.1016/0026-0495(95)90231-7. Metabolism. 1995. PMID: 7476303 Review.

2

The influence of oral glucose loading on the insulin response to i.v. glucagon in children and adolescents.

Josefsberg Z, Flatau E, Doron M, Laron Z. Josefsberg Z, et al. Among authors: laron z. Metabolism. 1976 Mar;25(3):277-80. doi: 10.1016/0026-0495(76)90085-8. Metabolism. 1976. PMID: 1250162

3

Growth hormone and insulin-like growth factor regulate insulin-like growth factor-binding protein-1 in Laron type dwarfism, growth hormone deficiency and constitutional short stature.

Laron Z, Suikkari AM, Klinger B, Silbergeld A, Pertzelan A, Seppälä M, Koivisto VA. Laron Z, et al. Acta Endocrinol (Copenh). 1992 Oct;127(4):351-8. doi: 10.1530/acta.0.1270351. Acta Endocrinol (Copenh). 1992. PMID: 1280392

4

Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism.

Laron Z, Anin S, Klipper-Aurbach Y, Klinger B. Laron Z, et al. Lancet. 1992 May 23;339(8804):1258-61. doi: 10.1016/0140-6736(92)91594-x. Lancet. 1992. PMID: 1349669

5

Growth hormone therapy in normal short children induces a transitory decrease in plasma growth hormone releasing hormone levels and in human growth hormone responsiveness to exogenous growth hormone releasing hormone.

Gil-Ad I, Klinger B, Pertzelan A, Erster B, Silbergeld A, Talpaz H, Laron Z. Gil-Ad I, et al. Among authors: laron z. J Endocrinol Invest. 1992 Nov;15(10):735-9. doi: 10.1007/BF03347642. J Endocrinol Invest. 1992. PMID: 1362733

6

Effect of insulin-like growth factor I on the thyroid axis in patients with Laron-type dwarfism and healthy subjects.

Klinger B, Ionesco A, Anin S, Laron Z. Klinger B, et al. Among authors: laron z. Acta Endocrinol (Copenh). 1992 Dec;127(6):515-9. doi: 10.1530/acta.0.1270515. Acta Endocrinol (Copenh). 1992. PMID: 1362849 Clinical Trial.

7

IGF binding protein 3 in patients with Laron type dwarfism: effect of exogenous rIGF-I.

Laron Z, Klinger B, Blum WF, Silbergeld A, Ranke MB. Laron Z, et al. Clin Endocrinol (Oxf). 1992 Mar;36(3):301-4. doi: 10.1111/j.1365-2265.1992.tb01449.x. Clin Endocrinol (Oxf). 1992. PMID: 1373347

8

Serum prolactin in patients with Laron-type dwarfism: effect of insulin-like growth factor I.

Silbergeld A, Klinger B, Schwartz H, Laron Z. Silbergeld A, et al. Among authors: laron z. Horm Res. 1992;37(4-5):160-4. doi: 10.1159/000182302. Horm Res. 1992. PMID: 1490658

9

Erythrocytes from patients with low serum concentrations of IGF-I have an increase in receptor sites for IGF-I.

Eshet R, Duz Z, Silbergeld A, Koren R, Klinger B, Laron Z. Eshet R, et al. Among authors: laron z. Acta Endocrinol (Copenh). 1991 Oct;125(4):354-8. doi: 10.1530/acta.0.1250354. Acta Endocrinol (Copenh). 1991. PMID: 1659764

10

Optimum use of growth hormone in children.

Laron Z, Butenandt O. Laron Z, et al. Drugs. 1991 Jul;42(1):1-8. doi: 10.2165/00003495-199142010-00001. Drugs. 1991. PMID: 1718681 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

664 results

Search Page

Filters